Tag: drugmaker-said
-
FDA lifts hold on AstraZeneca head and neck cancer trials
LONDON (Reuters) – U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for…
-
FDA lifts hold on AstraZeneca head and neck cancer trials
LONDON (Reuters) – U.S. officials have given a green light for two clinical trials testing AstraZeneca's cancer immunotherapy drug durvalumab in head and neck cancer to resume recruiting patients, lifting a hold imposed following cases of bleeding. The British drugmaker said on Tuesday that one of the late-stage Phase III trials had already re-opened for…
-
NHL-Highlights of Monday’s NHL games
Highlights of Sunday’s National Hockey League games: Oilers 5, Blackhawks 0 After years of being tormented by their longtime nemesis from Chicago, the Edmonton Oilers gained a measure of revenge on Monday night with a 5-0 victory over the Blackhawks at Rogers Place Arena. Cam Talbot made 31 saves for the shutout as Edmonton beat…
-
Mexico, Central America seek joint strategy on migrants as Trump looms
By Sofia Menchu GUATEMALA CITY (Reuters) – The foreign ministers of Mexico, El Salvador, Honduras and Guatemala met on Monday to form a strategy to protect their migrants in the United States, in a show of regional solidarity following Donald Trump's win in the U.S. presidential election. Trump's election upset has sent shockwaves through Mexico…
-
Regulators, railroads target sleep apnea in wake of crash
NEW YORK (AP) — Engineers suffering from sleep apnea must have the fatigue-inducing disorder under control before they will be allowed to operate trains for the New Jersey commuter railroad whose train slammed into a station in September, killing a woman and injuring more than 100 people.
-
Allergan expands buyback to $15 billion, sets first quarterly dividend
The drugmaker said it was initiating a regular quarterly cash dividend of 70 cents per share. The company was created when Dublin-based Actavis bought the Botox maker in March 2015, snatching it from hostile bidder Valeant Pharmaceuticals Inc , and taking on the Allergan name. Allergan Chief Executive Brent Saunders has orchestrated a string of…
-
Lilly says new type of pain drug could lessen need for opioids
Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain. The Indianapolis drugmaker said tanezumab, given by injection every eight weeks, could be a far…
-
Lilly says new type of pain drug could lessen need for opioids
Eli Lilly and Co on Tuesday said it and partner Pfizer Inc aim to seek approval by 2018 for a new type of pain drug that could be an alternative to opioids for osteoarthritis, chronic back pain and cancer pain. The Indianapolis drugmaker said tanezumab, given by injection every eight weeks, could be a far…
-
SEC raises concerns about Valeant’s use of ‘Non-GAAP’ measures
The SEC has questioned Valeant's practice of stripping away acquisition-related expenses from its “non-GAAP” or adjusted metrics, given that the drugmaker had been fueling growth through frenzied deal making. In multiple letters, the SEC said Valeant's management is in possession of all the facts and urged for adequate and accurate financial disclosures. “We are concerned…
-
SEC raises concerns about Valeant’s use of ‘Non-GAAP’ measures
The SEC has questioned Valeant's practice of stripping away acquisition-related expenses from its “non-GAAP” or adjusted metrics, given that the drugmaker had been fueling growth through frenzied deal making. In multiple letters, the SEC said Valeant's management is in possession of all the facts and urged for adequate and accurate financial disclosures. “We are concerned…